Keyword: National Institutes of Health (NIH)
The discovery of inherited genetic variants that raise the risk of prostate cancer could improve screening, treatment and prevention of the disease.
A Tufts team has published research that explains how A. baumannii builds a protective coating, allowing it to evade destruction from antibiotics.
Biotech developments over the past week include a new method for transferring memories and a compound that blocks cancer metastasis.
The past week saw the discovery of a genetic mutation that disrupts nerve signaling in ALS and the development of a noninvasive bladder cancer test.
Antibiotic R&D funding partnership CARB-X is putting up the cash to cut the time it takes to learn what pathogen is responsible for a case of sepsis.
Two studies uncover links between genes and brain-cell functioning that could provide new targets for therapies aimed at neurodegenerative diseases.
Two recent advances are focused on using engineered T cells and drug nanocrystals to combat the HIV “reservoirs” that hide in the body and cause the disease to re-emerge.
The NIH wants to speed up the development of gene-editing therapies—and is putting $190 million into a program to help make that happen.
Understanding how some helper T cells become killer T cells could lead to better vaccine design for HIV and hep C.
NIH scientists have modeled the 3D structure of DHHC enzymes, which modify EGFRs, which are implicated in a range of cancers.